Swipe om te navigeren naar een ander artikel
Multi-attribute utility instruments (MAUIs) are widely used to measure utility weights. This study sought to compare utility weights of two popular MAUIs, the EQ-5D-3L and the SF-6D, and inform researchers in the selection of generic MAUI for use with cardiovascular (CVD) patients.
Data were collected in the Young@Heart study, a randomised controlled trial of a nurse-led multidisciplinary home-based intervention compared to standard usual care. Participants (n = 598) completed the EQ-5D-3L and the SF-12v2, from which the SF-6D can be constructed, at baseline and at 24-month follow-up. This study examined discrimination, responsiveness, correlation and differences across the two instruments.
Both MAUIs were able to discriminate between the NYHA severity classes and recorded similar changes between the two time points although only SF-6D differences were significant. Correlations between the dimensions of the two MAUIs were low. There were significant differences between the two instruments in mild conditions but they were similar in severe conditions. Substantial ceiling and floor effects were observed.
Our findings indicate that the EQ-5D and the SF-6D cover different spaces in health due to their classification systems. Both measures were capable of discriminating between severity groups and responsive to quality of life changes in the follow-up. It is recommended to use the EQ-5D-3L in severe and the SF-6D in mild CVD conditions.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
National Institute for Health and Care Excellence (NICE). (2008). Guide to the methods of technology appraisal. London: NICE.
Euro Qol group. EQ5D: EuroQol; 2011 Retrieved from: http://www.euroqol.org/eq-5d/reference-search/reference-search.html.
AQoL. Assessment of Quality of life 2011 Retrieved from: http://www.aqol.com.au/research-papers.html.
Pharmaceutical Benefits Advisory Committee. Guidelines for preparing submissions to the Pharmaceutical Benefits Advisory Committee 2015 [Appendix 7.2]. Retrieved from: https://pbac.pbs.gov.au/content/information/printable-files/pbacg-book.pdf.
Australian Institute of Health and Welfare. Impact of cardiovascular disease. (2015). Retrieved from: http://www.aihw.gov.au/cardiovascular-health/impact/.
Centers for Disease Control and Prevention Heart Disease. (2015). Retrieved from: http://www.cdc.gov/heartdisease/facts.htm.
European Heart Network. European cardiovascular disease statistics 2012 2015. Retrieved from: http://www.ehnheart.org/cvd-statistics.html.
British Heart Foundation. Heart statistics 2015 Retrieved from: https://www.bhf.org.uk/research/heart-statistics.
Feeny, D., Spritzer, K., Hays, R. D., Liu, H., Ganiats, T. G., Kaplan, R. M., et al. (2012). Agreement about identifying patients who change over time: cautionary results in cataract and heart failure patients. Medical Decision Making: An International Journal of the Society for Medical Decision Making, 32(2), 273–286. CrossRef
Chan, Y.-K., Stewart, S., Calderone, A., Scuffham, P., Goldstein, S., & Carrington, M. J. (2012). Exploring the potential to remain “Young @ Heart”: Initial findings of a multi-centre, randomised study of nurse-led, home-based intervention in a hybrid health care system. International Journal of Cardiology, 154(1), 52–58. CrossRefPubMed
Carrington, M. J., Chan, Y. K., Calderone, A., Scuffham, P. A., Esterman, A., Goldstein, S., et al. (2013). A multicenter, randomized trial of a nurse-led, home-based intervention for optimal secondary cardiac prevention suggests some benefits for men but not for women: the Young at Heart study. Circulation: Cardiovascular Quality of Outcomes, 6(4), 379–389.
Antes, G. (2010). The new CONSORT statement. BMJ: British Medical Journal, 340(7748), 666–667.
Ramos-Goñi, J. M., & Rivero-Arias, O. (2011). eq5d: A command to calculate index values for the EQ-5D quality-of-life instrument. Stata Journal, 11(1), 120–125.
Kularatna, S., Whitty, J. A., Johnson, N. W., Jayasinghe, R., & Scuffham, P. A. (2016). A comparison of health state utility values associated with oral potentially malignant disorders and oral cancer in Sri Lanka assessed using the EQ-5D-3 L and the EORTC-8D. Health Quality of Life Outcomes, 14, 101. CrossRefPubMedPubMedCentral
Teckle, P., Peacock, S., McTaggart-Cowan, H., van der Hoek, K., Chia, S., Melosky, B., et al. (2011). The ability of cancer-specific and generic preference-based instruments to discriminate across clinical and self-reported measures of cancer severities. Health Quality of Life Outcomes, 9, 106. CrossRefPubMedPubMedCentral
National Institute for Health and Care Excellence (NICE). (2001). Technical guidance for manufacturers and sponsors on making a submission to a technology appraisal. London: NICE.
- Comparison of the EQ-5D-3L and the SF-6D (SF-12) contemporaneous utility scores in patients with cardiovascular disease
Yih Kai Chan
Chantal F. Ski
Paul A. Scuffham
- Springer International Publishing